Anika Therapeutics (ANIK) Earnings Date, Estimates & Call Transcripts $8.35 -0.42 (-4.79%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$8.36 +0.01 (+0.06%) As of 08:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Anika Therapeutics Earnings Summary Anika Therapeutics released Q4 2024 earnings on March 12, 2025, reporting an EPS of -$0.14, which missed analysts' consensus estimates of -$0.01 by $0.13. Quarterly revenue was reported to be $30.60 million, above analyst estimates of $29 million. With a trailing EPS of -$4.15, Anika Therapeutics' earnings are expected to grow next year, from ($0.84) to ($0.41) per share. Latest Q4 Earnings DateMar. 12EstimatedConsensus EPS (Mar. 12) -$0.01 Actual EPS (Mar. 12) -$0.14 Missed By -$0.13 Actual Revenue (Mar. 12) $30.60MQ4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Annual Report (10-K)Slide DeckFull Screen Slide DeckPowered by Get Anika Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anika Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataANIK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANIK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Anika Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251$0.22$0.22$0.22Q2 20251$0.26$0.26$0.26Q3 20251$0.39$0.39$0.39Q4 20251$0.44$0.44$0.44 FY 2025 4 $1.31 $1.31 $1.31 Q1 20261-$0.16-$0.16-$0.16Q2 20261-$0.14-$0.14-$0.14Q3 20261-$0.09-$0.09-$0.09Q4 20261-$0.09-$0.09-$0.09 Anika Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/12/2025Q4 2024-$0.01-$0.14 -$0.13-$1.50$29.00M$30.60M8/8/2024Q2 2024$0.23-$0.01 -$0.24$0.01$39.90M$41.92M5/8/2024Q1 2024$0.13$0.09 -$0.04$0.49$39.23M$40.52M3/13/2024Q4 2023-$0.15$0.05+$0.20$4.40$41.51M$42.97M8/8/2023Q2 2023-$0.27-$0.06+$0.21$0.07$40.61M$44.30M Anika Therapeutics Earnings - Frequently Asked Questions When did Anika Therapeutics announce their last quarterly earnings? Anika Therapeutics (NASDAQ:ANIK) last announced its quarterly earning data on Wednesday, March 12, 2025. Learn more on ANIK's earnings history. Did Anika Therapeutics beat their earnings estimates last quarter? In the previous quarter, Anika Therapeutics (NASDAQ:ANIK) missed the analysts' consensus estimate of ($0.01) by $0.13 with a reported earnings per share (EPS) of ($0.14). Learn more on analysts' earnings estimate vs. ANIK's actual earnings. How can I listen to Anika Therapeutics' earnings conference call? The conference call for Anika Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Anika Therapeutics' conference call transcript? The conference call transcript for Anika Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does Anika Therapeutics generate each year? Anika Therapeutics (NASDAQ:ANIK) has a recorded annual revenue of $119.91 million. How much profit does Anika Therapeutics generate each year? Anika Therapeutics (NASDAQ:ANIK) has a recorded net income of -$56.38 million. ANIK has generated -$4.15 earnings per share over the last four quarters. What is Anika Therapeutics' EPS forecast for next year? Anika Therapeutics' earnings are expected to grow from ($0.84) per share to ($0.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies ANVS Earnings CERS Earnings OSUR Earnings UTMD Earnings WST Earnings COO Earnings ALGN Earnings MMSI Earnings HAE Earnings ICUI Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk ProductionAmazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic? This page (NASDAQ:ANIK) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredMissed out on Bitcoin gains?Even bigger crypto gains coming?A crypto storm is coming Right now, conditions are in place for a historic ...Stansberry Research | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
